• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBill Ackman

Bill Ackman

Page 18 of 19
SEC Chair Mary Jo White
Finance
SEC’s Mary Jo White criticizes shareholder activism and Bill Ackman deal
By Stephen GandelMarch 19, 2015
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
The FBI is looking into possible Herbalife stock manipulation
By John KellMarch 13, 2015
Inside The South By Southwest (SXSW) Interactive Festival
Features
FBI probes Ackman and SXSW kicks off — 5 things to know today
By Laura LorenzettiMarch 13, 2015
Actavis CEO Brenton Saunders and Allergan CEO David Pyotton pose together on the floor of the New York Stock Exchange
Finance
Allergan CEO: How to survive an activist attack
By Stephen GandelFebruary 12, 2015
Passive investors crushed the activists in 2014
Finance
Passive investors crushed the activists in 2014
By Stephen GandelJanuary 9, 2015
Icahn Enterprises L.P. To Ring The NASDAQ Stock Market Closing Bell
Leadership
Why activist investors are getting even more…active
By Paul HodgsonDecember 3, 2014
Activist investors: The best (and worst) performers of 2014
Finance
Activist investors: The best (and worst) performers of 2014
By Stephen GandelDecember 3, 2014
Actavis CEO Brenton Saunders and Allergan CEO David Pyotton pose together on the floor of the New York Stock Exchange
Finance
Allergan CEO hands Botox maker to lawyer instead of consultant
By Stephen GandelNovember 17, 2014
Botox
Finance
Actavis agrees to buy Botox-maker Allergan for $66 billion
By John KellNovember 17, 2014
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Zoetis shares spike on reported Ackman stake purchase
By Tom Huddleston Jr.November 11, 2014
184366121
Leadership
Vote: Businessperson of the Year – Wall Street MVPs
By Stephen GandelNovember 11, 2014
Did Bill Ackman just kill the poison pill?
Finance
Did Bill Ackman just kill the poison pill?
By Stephen GandelNovember 6, 2014
Is Valeant the wrong partner for Bill Ackman’s bid for Allergan?
Finance
Is Valeant the wrong partner for Bill Ackman’s bid for Allergan?
By Sanjay SanghoeeOctober 30, 2014
Starbucks To Raise Prices On Select Drinks, And Lower On Simple Drinks
Features
Starbucks schedules and bitcoin on eBay — five things to know today
By Ben GeierAugust 15, 2014
Finance
Finance
A look at how some of the top investors, hedge funds spent the second quarter
By Tom Huddleston Jr.August 14, 2014
1...
  • 15
  • 16
  • 17
  • 18
  • 19
19
Most Popular
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.